Physician Assistant · Dayton, OH
NPI
1285009837
Since 2015
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5300 Far Hills Ave
Dayton, OH, 45429
Phone (937) 433-7536
Groups this clinician bills Medicare through
Medicare paid, 2024
$223K
5,617 services
Medicare patients, 2024
1,367
Average age 74
Drug cost, 2024
$880K
3,172 prescriptions
Company payments, 2025
$5,221
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Srikanth Vangapandu was code 99213 (office e&m - established), 1,359 times for 963 patients. In total Srikanth Vangapandu billed 5,617 services in 75 codes, and Medicare paid $223K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,359 | 963 | $45.94 | $62K |
| 17003 Destruction Skin Lesion | Office | 1,268 | 289 | $3.76 | $4,772 |
| 17000 Destruction Skin Lesion | Office | 589 | 464 | $28.78 | $17K |
| 11102 Skin Biopsy | Office | 374 | 321 | $49.62 | $19K |
| 17110 Destruction Skin Lesion | Office | 303 | 264 | $58.95 | $18K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 256 | 85 | $0.54 | $140 |
| 99214 Office E&M - Established | Office | 255 | 205 | $69.06 | $18K |
| 99203 Office E&M - New | Office | 219 | 219 | $50.75 | $11K |
| 11103 Skin Biopsy | Office | 149 | 81 | $31.14 | $4,639 |
| 99212 Office E&M - Established | Office | 123 | 106 | $30.26 | $3,722 |
| 96372 Injection Administration | Office | 66 | 60 | $6.98 | $460 |
| 11300 Removal or Shaving of Skin Growth | Office | 49 | 40 | $43.14 | $2,114 |
| 17262 Destruction Skin Lesion | Office | 49 | 43 | $90.61 | $4,440 |
| 13121 Wound Repair - All Levels | Office | 48 | 43 | $254.40 | $12K |
| 11603 Skin Lesion Excision | Office | 36 | 33 | $87.94 | $3,166 |
By year: 2022 $208K for 6,107 services; 2023 $215K for 6,139 services; 2024 $223K for 5,617 services.
Medicare prescription drug claims, 2024
In 2024, the drug Srikanth Vangapandu prescribed most often to Medicare patients was Triamcinolone Acetonide, with 389 prescriptions and refills. In total Srikanth Vangapandu wrote 3,172 Medicare prescriptions that cost $880K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 389 | 424 | 290 | $2,966 |
| Clobetasol Propionate Generic | 386 | 407 | 234 | $16K |
| Mupirocin Generic | 372 | 375 | 300 | $2,097 |
| Fluorouracil Generic | 246 | 249 | 211 | $24K |
| Cephalexin Generic | 244 | 244 | 220 | $947 |
| Ketoconazole Generic | 231 | 249 | 132 | $2,385 |
| Hydrocortisone Generic | 147 | 153 | 117 | $618 |
| Clindamycin Phosphate Generic | 142 | 163 | 81 | $7,881 |
| Doxycycline Hyclate Generic | 111 | 125 | 46 | $1,527 |
| Terbinafine Hcl Generic | 49 | 61 | 34 | $303 |
| Tacrolimus Generic | 48 | 51 | 29 | $7,627 |
| Imiquimod Generic | 44 | 51 | 23 | $1,583 |
| Nystatin Generic | 41 | 46 | 26 | $597 |
| Fluocinonide Generic | 40 | 46 | 24 | $1,470 |
| Metronidazole Generic | 39 | 45 | 23 | $1,455 |
Brand drugs: 255 claims; generic drugs: 2,917 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Srikanth Vangapandu $5,221 ($5,221 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $793.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 61 | $793 |
| Janssen Biotech, Inc. JNJ | 45 | $758 |
| Journey Medical Corporation DERM | 10 | $560 |
| UCB, Inc. UCB.BR | 24 | $535 |
| Pfizer Inc. PFE | 22 | $354 |
| E.R. Squibb & Sons, L.L.C. BMY | 23 | $330 |
| Lilly USA, LLC LLY | 16 | $313 |
| Incyte Corporation INCY | 38 | $278 |
| Arcutis Biotherapeutics, Inc. ARQT | 22 | $224 |
| Galderma Laboratories, L.P. GALD.SW | 19 | $212 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.